한림대학교성심병원

최하영 교수

1577-5587 hchoi@hallym.or.kr
  • 진료과 호흡기-알레르기내과

전문진료분야

결핵 및 호흡기 감염, 기관지확장증, 폐암

전화 예약 1577-5587
교수님사진

(주간) 진료시간표 (2024-07-15 ~ 2024-07-20)

진료시간표
진료시간
오전 외래진료외래진료외래진료
오후 외래진료
교수님 사진

기본정보

학력

학력

2001 ~ 2007전남대학교 의학대학 졸업

2012 ~ 2014전남대학교 대학원 의학석사 졸업

2019 ~ 2022성균관대학교 대학원 의학박사 졸업

경력

경력

2007 ~ 2010공중보건의

2010 ~ 2010Cooper University Hospital 단기연수

2011 ~ 2012전남대학교병원 인턴

2012 ~ 2016전남대학교병원 레지던트

2016 ~ 2017삼성서울병원 임상강사

2017 ~ 2018한림대학교강남성심병원 호흡기내과 임상조교수

2018 ~ 2023한림대학교강남성심병원 호흡기내과 조교수

2018 ~ 2023한림대학교 의과대학 조교수

2022 ~ 2023영국 University of Dundee 연수

2023 ~ 한림대학교 의과대학 부교수

학회활동

학회활동

2007 ~ 대한의사협회 회원

2012 ~ 대한내과학회 회원

2015 ~ 대한결핵 및 호흡기학회 회원

2017 ~ 대한중환자의학회 회원

2019 ~ 미국흉부학회 회원

2020 ~ 유럽호흡기학회 회원

2020 ~ 대한천식알레르기학회 회원

수상이력

수상이력

2019 ~ 2022미래창조과학부 생애첫연구 연구비 수혜

2019Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들

2020대한결핵 및 호흡기학회 우수 초록상

2021 ~ 2026교육부 지역대학우수과학자 연구비 수혜

2021Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들

20212nd European NTM & Bronchiectasis Workshop Best Oral Presentation

2021대한결핵 및 호흡기학회 젊은 호흡기 연구자상

2022Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(2회 선정)

2023Biology Research Information Center (BRIC) 선정 한국을 빛내는 사람들(5회 선정)

20233rd European Bronchiectasis Workshop Call For Proposal Winners 수상

논문

📌 Publications as the first author or corresponding author

1. Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med 2023;208:1166.

2. Association between non-cystic fibrosis bronchiectasis and the risk of incident dementia: A nationwide cohort study. Chron Respir Dis 2023;20.

3. Increased Lung Cancer Risk and Associated Risk Factors in Tuberculosis Survivors: A Korean Population-Based Study. Clin Infect Dis 2023;77:1329.

4. Systemic sclerosis and risk of bronchiectasis: a nationwide longitudinal cohort study. Arthritis Res Ther 2023;25:209.

5. Impact of allergic disease on the risk of mycobacterial disease. J Allergy Clin Immunol Pract 2023;11:2830.

6. Bioinformatics Analysis of Gene Expression Profiles for Diagnosing Sepsis and Risk Prediction in Patients with Sepsis. Int J Mol Sci 2023;24:9362.

7. Gastroesophageal reflux disease increases susceptibility to non-tuberculous mycobacterial pulmonary disease. Chest 2023;163:270.

8. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clin Infect Dis 2023;76:e973.

9. Impacts of asthma in patients with bronchiectasis: findings from the KMBARC registry. AllergyAsthma Immunol Res 2023;15:83.

10. Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis. Respir Res 2022;23:288.

11. Non-Cystic Fibrosis Bronchiectasis Increases the Risk of Lung Cancer Independent of Smoking Status. Ann Am Thorac Soc 2022:19;1551.

12. Plasma Mitochondrial DNA and Necroptosis as Prognostic Indicators in Critically Ill Patients with Sepsis. Biomedicines 2022;10:2386.

13. Female reproductive factors and incidence of non-tuberculous mycobacterial pulmonary disease among postmenopausal women in Korea. Clin Infect Dis 2022;75:1397.

14. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study. Pharmacoepidemiol Drug Saf 2022;31:1153.

15. Risk Factors of Incident Lung Cancer in Patients with Non-Cystic Fibrosis Bronchiectasis: A Korean Population-Based Study. Cancers 2022;14:2604.

16. Trends in Influenza Vaccination Rates in Participants With Airflow Limitation: The Korea National Health and Nutrition Examination Survey 2007–2018. Front Med 2022;9:870617.

17. Association between Smoking Status and Incident Non-Cystic Fibrosis Bronchiectasis in Young Adults: A Nationwide Population-Based Study. J Pers Med 2022;12:691.

18. Healthcare Utilization and Medical Cost of Gastrointestinal Reflux Disease in Non-tuberculous Mycobacterial Pulmonary Disease: A Population-Based Study, South Korea, 2009–2017. Front Med 2022;9:793453.

19. Pulmonary Tuberculosis and the Incidence of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc 2022;19:640.

20. Developing a Diagnostic Bundle for Bronchiectasis in South Korea: A Modified Delphi Consensus Study. Tuberc Respir Dis 2022;85:56.

21. Gastro-oesophageal reflux disease increases healthcare use and medical costs in patients with bronchiectasis: a Korean nationwide population-based study. Therap Adv Gastroenterol 2021;14:17562848211062801.

22. Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study. Front Nutr 2021;8:739766.

23. Predicting Factors of Severe COVID-19 in Patients With Asthma: A Korean National Cohort Study. Allergy Asthma Immunol Res 2021;13:939.

24. Impact of COVID-19 on TB epidemiology in South Korea. IntJ Tuberc Lung Dis 2021;25:854.

25. Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry. J Clin Med 2021;10:4542.

26. Being Underweight Increases the Risk of Non-Cystic Fibrosis Bronchiectasis in the Young Population: A Nationwide Population-Based Study. Nutrients 2021;13:3206.

27. Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study. J Thorac Dis 2021;13:4894.

28. Association of Ventilatory Disorders with Respiratory Symptoms, Physical Activity, and Quality of Life in Subjects with Prior Tuberculosis: A National Database Study in Korea. J Pers Med 2021;11:678.

29. Increased Incidence and Associated Risk Factors of Aspergillosis in Patients with Bronchiectasis. J Pers Med 2021;11:422.

30. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J 2021;58:2004125.

31. Characteristics of bronchiectasis in Korea: First data from the Korean Multcentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries. Respirology 2021;26:619.

32. Efficacy and dose of afatinib in patients with non-small cell lung cancer after failure of prior gefitinib or erlotinib treatment. Thorac Cancer 2021;12:1598.

33. Increased mortality in patients with non cystic fibrosis bronchiectasis respiratory comorbidities. Sci Rep 2021;11:7126.

34. Impact of bronchiectasis on susceptibility to and severity of COVID-19: a nationwide cohort study. Ther Adv Respir Dis 2021;15.

35. Impact of Bronchiectasis on incident NTM pulmonary disease: A 10-Year national cohort study. Chest 2021;159:1807.

36. Risk of Coronavirus Disease Incidence, Severe Presentation, and Mortality in Patients with Lung Cancer. Cancer Res Treat 2021;53:678.

37. Body mass index change and incident asthma in adults: A nationwide cohort study. Allergy 2021;76:1896.

38. Impact of the severity of restrictive spirometric pattern on nutrition, physical activity, and quality of life: results from a nationally representative database. Sci Rep 2020;10:19672.

39. Factors Associated Bronchiectasis in Korea: A National Database Study. Ann Transl Med 2020;8:1350.

40. Incidence of Bronchiectasis concerning Tuberculosis Epidemiology and Other Ecological Factors: A Korean National Cohort Study. ERJ Open Res 2020;6:00097-2020.

41. Bronchiectasis and Increased Mortality in Patients with Corticosteroid-Dependent Severe Asthma: a nationwide population study. Ther Adv Respir Dis 2020;14.

42. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study. BMC Cancer 2020;20:825.

43. Outcomes of Extended Duration Therapy for Drug-Susceptible Cavitary Pulmonary Tuberculosis. Ann Transl Med 2020;8:346.

44. Impact of Bronchiectasis on Postoperative Pulmonary Complications after Extra-pulmonary Surgery in Patients with Airflow Limitation. J Korean Med Sci 2020;35:e80.

45. KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. BMJ Open 2020;10:e034090.

46. The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. Ann Transl Med 2019;7:770.

47. Improved survival rates in patients with H1N1 acute respiratory failure in Korea between 2009 and 2016. PLoS One 2019;14:e0223323.

48. Population-based prevalence of bronchiectasis and associated comorbidities in South Korea. Eur Respir J 2019;54:1900194.

49. Early corticosteroid treatment for postoperative acute lung injury after lung cancer surgery. Ther Adv Respir Dis 2019;13:1753466619840256.

50. Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis. J Thorac Dis 2019;11:892.

51. Prevalence and clinical course of postoperative acute lung injury after esophagectomy for esophageal cancer. J Thorac Dis 2019;11:200.

52. Prevalence of and factors related to latent tuberculous infection among all employees in a referral hospital. Int J Tuberc Lung Dis 2018;22:1329.

53. Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease. Diagn Microbiol Infect Dis 2018;90:293.

54. Pulmonary actinomycosis mimicking lung cancer on positron emission tomography. Ann Thorac Med 2017;12:121.

55. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease. Antimicrob Agents Chemother 2017;61.

56. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease. Antimicrob Agents Chemother 2017;61.

57. Clinical and Laboratory Differences between Lymphocyte- and Neutrophil-Predominant Pleural Tuberculosis. PLoS One 2016;11:e0165428.

58. Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma. Thorac Cancer 2015;6:224.


📌 Publications as the co-author

1. Impact of air pollution on healthcare utilization in patients with bronchiectasis. Front Med 2023;10:1233516.

2. The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study. Korean J Intern Med 2023;38:714.

3. Tuberculosis and risk of Parkinson's disease: A nationwide cohort study. Pulmonology 2023;29:250.

4. Diagnostic Utility and Tendency of Bronchial and Serum Soluble Receptor for Advanced Glycation EndProducts (sRAGE) in Lung Cancer. Cancers 2023;15:2819.

5. Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study. Clin Infect Dis 2023;76:1576.

6. Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study. Front Med 2023;10:1159227.

7. Clinical Outcome and Prognosis of a Nosocomial Outbreak of COVID-19. J Clin Med 2023;12:2279.

8. Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study. J Korean Med Sci 2023;38:e3.

9. Clinical Prognosis of Lung Cancer in Patients with Moderate Chronic Kidney Disease. Cancers 2022;14:4786.

10. Tuberculosis and Risk of Ischemic Stroke: A Nationwide Cohort Study. Stroke 2022;53:3401.

11. Pulmonary embolism and inferior vena cava thrombosis in a young male patient after mRNA-1273 (Moderna) immunization: A case report. Tuberc Respir Dis 2022;85:361.

12. Chronic Obstructive Pulmonary Disease is Associated with a More Symptomatic Burden and Severe Presentation of COVID-19: A Korean National COVID-19 Cohort Study. Tohoku J Exp Med 2022;256:209.

13. Treatment Outcomes of Infectious and Non-infectious Acute Exacerbation of Myositis-Related Interstitial Lung Disease. Front Med 2022;8:801206.

14. Female Reproductive Factors and the Risk of Bronchiectasis: A Nationwide Population-Based Longitudinal Study. Biomedicines 2022;10:303.

15. Predicting severe outcome using national early warning score (NEWS) in patients identified by a rapid response system: a retrospective cohort study. Sci Rep 2021;11.

16. Relationship between total cholesterol level and tuberculosis risk a nationwide longitudianl cohort. Sci Rep 2021;11.

17. Anemia, sarcopenia, physical activity, and the risk of tuberculosis in the older population: a nationwide cohort study. Ther Adv Chronic Dis 2021;12.

18. Revised Korean Cough Guidelines, 2020: Recommendations and Summary statements. Tuberc Respir Dis 2021;84:263.

19. Predicting unexpected deterioration of high-risk hopitalized patients during the COVID-19 pandemic: A multicenter cohort study. Resuscitation 2021;163:14.

20. Epidemiology and clinical features of common community human coronavirus disease. J Thorac Dis 2021;13:2288.

21. Hospitalization increases while economic status deteriorates in late stages of chronic obstructive pulmonary disease: the Korean National Health and Nutrition Examination Survey for 2007–2015. J Thorac Dis 2021;13:2160.

22. Clinical characteristics and treatment outcomes of Candida tracheobronchitis. Medicine (Baltimore) 2021;100:e24606.

23. Trends in the Prevalence of Non-tuberculous Mycobacterial Infection in Patients with Non-Cystic Fibrosis Bronchiectasis in South Korea, 2012-2016. Chest 2021;159:959.

24. Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations. Korean J Intern Med 2020.

25. Validation of the Korean Version of the Bronchiectasis Health Questionnaire. Tuberc Respir Dis 2020;83:228.

26. Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older. Respir Med 2019;157:52.

27. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer. Cancer Res Treat 2015;47:661.

28. Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor. Thorac Cancer 2015;6:800.

29. Pulmonary epithelioid hemangioendothelioma misdiagnosed as a benign nodule. World J Surg Oncol 2015;13:107.

30. A Case of Successful Percutaneous Coronary Intervention by Fractional Flow Reserve and 13N-Ammonia Positron Emission Tomography. J Lipid Atheroscler 2015;4:39.